News

VoxelSensors funding injection powers the future of immersive tech

Monday 22/05/2023

Blending physical and digital world through 3D perception VoxelSensors, a Brussels-based start-up founded by VUB alumni Ward van der Tempel and Johannes Peeters, recently announced that it has raised €5 million euros in an investment round.

Get to know Jessica Hekking

Tuesday 18/04/2023

Get to know Jessica Hekking Introducing Jessica, our Human & Social Sciences Valorisation Advisor at TechTransfer. She is the expert you can count on for any queries regarding opportunities, networking, proposal writing and more, in the field of applied research for SSHA. To get to know our team better, Jessica is sharing her story today! What is your role at VUB TechTransfer?

Get to know Kristel Mommaerts

Tuesday 18/04/2023

Introducing Kristel, our experienced Legal Counsel at VUB TechTransfer since 2005.

New VUB-UZ Brussel spin-off: Presscuff

Wednesday 12/04/2023

Presscuff's innovative tube reduces pneumonia incidence and saves lives. Presscuff, the world's first pressure-based endotracheal tube, was founded by Emiel Suijs, former head nurse of the Intensive Care Unit at UZ Brussel, VUB Prof Dr Spapen, former head of the Intensive Care Unit, and VUB-alumnus Evert Van Meeuwen.

vacature

Job offer: spin-off coach

Tuesday 04/04/2023

Join our TechTransfer team as a spin-off coach and contribute to bridging the gap between research and industry. As a spin-off coach, you will find yourself in the team op IP management and spin-off creation.

vacature

Job offer: head of VUB Foundation & Fellowship

Monday 03/04/2023

Are you passionate about innovation and making a difference? As Head of VUB Foundation and Fellowship at TechTransfer, you'll lead a team of 4 specialists, develop policies for raising funds and manage the network of VUB Fellows. You will report to the Director of TechTransfer, Vice Rector Innovation, and Board of Directors. Ready to make a difference?

Confo Therapeutics

Confo Therapeutics and Daiichi Sankyo team up to tackle CNS diseases

Friday 31/03/2023

Confo Therapeutics, a spin-off from VUB, has teamed up with Daiichi Sankyo to discover and develop small molecule drugs targeting G-protein coupled receptors (GPCRs) associated with central nervous system (CNS) diseases, which are conditions that affect the brain and spinal cord.

Konligo

Building a better future, one event at a time: Konligo’s circular approach

Wednesday 29/03/2023

Konligo, a VUB spin-off, is striving to become a 100% circular company. The company creates easy-to-set-up stands for events, exhibitions, and shows, with each part of their event infrastructure being replaceable or recyclable, and produced locally with recycled resources.

Hubert Rahier recycles war debris in Ukraine

Thursday 23/03/2023

Hubert Rahier, professor of physical chemistry at the VUB Materials & Chemistry research group, has been approached by the Ukrainian company Sheldor to assist in the recycling of concrete from buildings destroyed during the Russian conflict.

Discover our new brochure: ‘A world of difference’

Tuesday 21/03/2023

Want to know how the research at the five Flemish universities improves society? And what knowledge and technology transfer looks like in practice? Our new brochure introduces you in the world of research valorisation by means of 25 striking examples! Click here to see the brochure.

Confo Therapeutics

Confo Therapeutics announces global licensing agreement with Lily

Monday 20/03/2023

Confo Therapeutics, a spin-off of VUB and VIB and a leader in the discovery of medications that target G-protein coupled receptors (GPCRs), announced a worldwide licensing agreement with Eli Lilly and Company for their clinical-stage compound CFTX-1554 and related backup compounds.

Abscint, A VUB spin-off, receives allowance for U.S. patent

Tuesday 28/02/2023

Abscint's patented technology paves the way for personalized diagnosis and therapy. Abscint, a VUB spin-off, has recently been granted a notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent application.

First
Previous
…
8
9
10
11
12 (current)
13
14
15
16
…
Next
Last